Sanofi India Share Price (SANOFI)
Check the latest share price of Sanofi India, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Sanofi India Stock Performance
Get live Sanofi India share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹6,090Day's Price Range₹6,21952 Week's Low
52 Week's High
₹4,90252-Week Price Range₹10,314.2
| Returns % | |
| 1 Month Return | + 1.66 % |
| 3 Month Return | + 10.34 % |
| 1 Year Return | -10.11 % |
| 3 Year Return | -7.27 % |
| 5 Year Return | -22.69 % |
| Market Stats | |
| Previous Close | ₹6,172.50 |
| Open | ₹6,090.00 |
| Volume | 4,918.00 |
| Upper Circuit | ₹7,407.00 |
| Lower Circuit | ₹4,938.00 |
Sanofi India Fundamentals & Key Indicators
Check Sanofi India market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹14,157.69 Cr
Return on Equity (ROE)
47.15
PE Ratio (TTM)
34.26
Return on capital employed (ROCE)
47.94
Industry PE ratio
57.39
Beta (LTM)
0.37
P/B Ratio
16.36
Dividend Yield
1.91
PEG Ratio
-0.42
Quarterly Earnings Growth YOY
-12.52
EPS (TTM)
179.7
Sector
Pharmaceuticals
Book Value
374.17
Technical Analysis
Bullish
View Technical Analysis
How to invest in Sanofi India?
Investing in Sanofi India is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Sanofi India or SANOFI on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Sanofi India or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Sanofi India with just a few clicks!
Sanofi India Stock's Interest Amongst Investors
Sanofi India Valuation
Track how Sanofi India P/E has moved over time to understand its valuation trends.
Sanofi India in the last 5 years
Lowest (0.00x)
December 29, 2023
Today (34.26x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (42.25x)
June 12, 2024
Today’s Price to Earnings Ratio: 34.26x
Sanofi India Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Sanofi India.
based on 3 analysts
75.00%
Buy
0.00%
Hold
25.00%
Sell
75% of analysts recommend a 'BUY' rating for Sanofi India. Average target price of ₹6814
Source: S&P Global Market Intelligence
Sanofi India Share Price Target
Get share price movements and forecasts by analysts on Sanofi India.
Sanofi India price forecast by 3 analysts
Upside of10.84%
High
₹7560
Target
₹6814.00
Low
₹5800
Sanofi India target price ₹6814, a slight upside of 10.84% compared to current price of ₹6147.5. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Sanofi India revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Sanofi India EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Sanofi India Financial Results
Get the annual and quarterly financial summary of Sanofi India, including revenue, profit, loss and more.
Indices Featuring Sanofi India Stock
Check stock indices that include Sanofi India.
Sanofi India Earnings and Dividends
View detailed summary of the earnings and dividend history of Sanofi India.
Sanofi India Ltd Earnings Results
Sanofi India Ltd’s net profit fell -33.7% since last year same period to ₹91.30Cr in the Q3 2024-2025. On a quarterly growth basis, Sanofi India Ltd has generated 11.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsSanofi India Ltd Dividends February,2025
In the quarter ending December 2024, Sanofi India Ltd has declared dividend of ₹117 - translating a dividend yield of 1.90%.
Read More about Dividends
Sanofi India Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sanofi India.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 60.4% | 0.00 | |
| Foreign Institutions | 5.57% | 0.00 | |
| Mutual Funds | 11.26% | 0.00 | |
| Retail Investors | 11.01% | 0.00 | |
| Others | 11.76% | 0.00 |
Sanofi India vs Peers
Compare market cap, revenue, PE, and other key metrics of Sanofi India with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 14,157.69 | -4.54% | 0.52 | 413 | 2,013 | |
| BUY | 67,394.66 | 9.93% | 0.56 | 3,168 | 29,001 | |
| HOLD | 98,102.78 | 32.58% | 0.64 | 3,854 | 19,547 | |
| BUY | 66,969.38 | 19.17% | 0.53 | NA | NA | |
| BUY | 55,819.29 | 27.46% | 0.56 | 927 | 3,749 |
Sanofi India News & Key Events
Latest news and events in one place to help you make informed investing decisions in Sanofi India.
Sanofi India Reports Mixed Q4 FY25 Results - 14 May, 2025
Sanofi India reported a mixed performance for Q4 FY25, with net profit declining 12.5% to ₹119.5 crore, while revenue increased by 4.9% to ₹535.9 crore. EBITDA surged 25%, reflecting improved operational efficiency.Sanofi Gains Approval for Beyfortus in India - 28 Apr, 2025
Sanofi's Beyfortus has received marketing authorization approval in India, allowing for improved immunization access for children through a partnership with Dr. Reddy's.Sanofi India Denies Rumors of Lantus Sale - 16 Apr, 2025
Sanofi India has refuted claims regarding the sale or licensing of its insulin brand, Lantus, stating that the information is unfounded and incorrect. The company has no plans to divest its flagship product.
Insights on Sanofi India Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 11.05% to 11.26% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 138.3%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 55.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 60.40% of holdings in Mar 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 3 years, SANOFI stock has moved down by -7.3%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 11.04% to 11.01% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 5.63% to 5.57% in Mar 2025 quarter
About Sanofi India
Revenue: ₹535.90Cr as on March 2025 (Q4 FY25)
Net Profit: ₹119.50Cr as on March 2025 (Q4 FY25)
Listing date: 06 Dec, 1994
Chairperson Name: Aditya Narayan
| Organisation | Sanofi India Ltd |
| Industry | Pharmaceuticals |
| CEO | Aditya Narayan |
| E-voting on shares | Click here to vote |
Mutual Funds that own Sanofi India
Check out the Mutual Funds with significant holdings in Sanofi India.
FAQs
What is Sanofi India share price today?
Sanofi India share price today stands at ₹6147.5, Open: ₹6090, Previous Close: ₹6172.5, High: ₹6219, Low: ₹6090, 52 Week High: ₹10314.2, 52 Week Low: ₹4902.
What is today's traded volume of Sanofi India?
Today's traded volume of Sanofi India is 4,918.00. Which means that 4,918.00 shares of Sanofi India were bought and sold on the stock market during today's trading session.
What is Sanofi India's market cap today?
Today's market capitalisation of Sanofi India is ₹14,157.69 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Sanofi India?
Sanofi India’s 52 week high is ₹10314.2 and 52 week low is ₹4902. The current share price of Sanofi India is ₹6147.5, which is -40.40% down from its 52 week high and 25.41% up from its 52 week low.